10,499
Total Claims
$1.9M
Drug Cost
2,241
Beneficiaries
$867
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
+21%
Cost per patient vs peers
$867 vs $719 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 9,058 claims · $216K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 514 | $710K |
| Rivaroxaban | 299 | $426K |
| Alirocumab | 110 | $145K |
| Dronedarone Hcl | 50 | $94K |
| Evolocumab | 70 | $88K |
| Sacubitril/Valsartan | 47 | $67K |
| Metoprolol Succinate | 1,023 | $24K |
| Dapagliflozin Propanediol | 18 | $22K |
| Ticagrelor | 23 | $19K |
| Ezetimibe | 382 | $16K |
| Atorvastatin Calcium | 1,050 | $13K |
| Rosuvastatin Calcium | 771 | $13K |
| Ranolazine | 36 | $11K |
| Icosapent Ethyl | 21 | $11K |
| Dabigatran Etexilate Mesylate | 12 | $9,667 |
Prescribing Profile
76
Unique Drugs
$1.2M
Patient Profile
78
Avg Age
53%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data